Solana Co (HSDT) — SEC Filings

Solana Co (HSDT) — 50 SEC filings. Latest: ARS (Apr 14, 2026). Includes 34 8-K, 4 10-Q, 3 DEF 14A.

View Solana Co on SEC EDGAR

Overview

Solana Co (HSDT) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Apr 9, 2026: On April 9, 2026, Solana Co. filed an 8-K report detailing changes in officers and compensatory arrangements. The filing includes exhibits related to these changes and financial statements, indicating potential shifts in the company's executive leadership and compensation structures.

Sentiment Summary

Across 50 filings, the sentiment breakdown is: 1 bullish, 5 bearish, 43 neutral, 1 mixed. The dominant filing sentiment for Solana Co is neutral.

Filing Type Overview

Solana Co (HSDT) has filed 1 ARS, 34 8-K, 2 EFFECT, 1 S-8, 4 10-Q, 3 DEF 14A, 1 S-1, 1 10-K, 1 SC 13G/A, 1 DEFA14A, 1 SC 13G with the SEC between May 2024 to Apr 2026.

Filings by Year

2026 · 2025 · 2024

Recent SEC Filings (50)

Solana Co SEC Filing History
DateFormDescriptionRisk
Apr 14, 2026ARSARS Filing
Apr 9, 20268-KSolana Co. Files 8-K: Officer Changes & Compensation Detailsmedium
Apr 9, 2026EFFECTEFFECT Filing
Apr 9, 2026EFFECTSolana Co. Registration Statement Declared Effectivelow
Mar 31, 2026S-8S-8 Filing
Nov 18, 202510-QSolana Co's Q3 Loss Balloons Amid Massive Digital Asset Bethigh
Nov 5, 20258-KSolana Co. Announces Director Changes and Officer Compensationlow
Nov 3, 20258-KSolana Co. Files 8-K: Regulation FD & Financialslow
Oct 31, 20258-K8-K Filing
Oct 29, 20258-KSolana Co. Files 8-K with Financialslow
Oct 21, 20258-KSolana Co. Files 8-K with Financialslow
Oct 16, 20258-KSolana Co. Appoints New Auditor, CohnReznick LLPlow
Oct 14, 2025DEF 14ASolana Co Seeks Shareholder Nod for Crypto Warrants, Board Seatmedium
Sep 29, 20258-KHelius Medical Technologies Files 8-Klow
Sep 25, 20258-KHelius Medical Technologies Files 8-K on Director Changes and Compensationmedium
Sep 22, 20258-KHelius Medical Technologies Files 8-Klow
Sep 18, 20258-KHelius Medical Technologies Files 8-K with Key Agreements and Officer Changesmedium
Sep 15, 20258-KHelius Medical Technologies (HSDT) Files 8-Klow
Aug 14, 202510-QHelius Medical's Net Loss Widens to $13.67M Amid Revenue Plungehigh
Jul 21, 20258-KHelius Medical Technologies Files 8-Kmedium

Risk Profile

Risk Assessment: Of HSDT's 44 recent filings, 6 were flagged as high-risk, 16 as medium-risk, and 22 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Financial Highlights

Solana Co Financial Summary (10-Q, Nov 18, 2025)
MetricValue
Revenue$697K
Net Income-$352.8M
EPS-$32.89
Debt-to-EquityN/A
Cash Position$124.1M
Operating MarginN/A
Total Assets$475.9M
Total Debt$628.3M

Key Executives

  • Dr. David L. Smith
  • Dr. Anya Sharma
  • Cosmo Jiang
  • Dane C. Andreeff
  • Jeffrey S. Mathiesen
  • Phillip D. Torrence, Esq.
  • N. Danny Shulman, Esq.
  • Barry I. Grossman, Esq.
  • Matthew Bernstein, Esq.
  • Justin Grossman, Esq.
  • Dr. Jonathan S. B. T. Hudson

Industry Context

The digital asset industry continues to be characterized by rapid innovation, high volatility, and an evolving regulatory landscape. Companies in this space often face challenges related to asset valuation, security, and compliance. Solana Co's strategy of building a digital asset treasury and commercializing hardware (PoNS device) places it at the intersection of blockchain infrastructure and specialized technology solutions.

Top Tags

corporate-governance (9) · 8-k (6) · filing (5) · sec-filing (5) · 8-K (5) · financials (4) · disclosure (3) · financial-reporting (3) · filing-update (3) · equity-sale (3)

Key Numbers

Solana Co Key Metrics
MetricValueContext
SEC Accession Number0001104659-26-041571Unique identifier for the filing
Number of Documents15Total documents included in the submission
Effectiveness Date2026-04-08The date the registration statement became effective.
Filing Acceptance Date2026-04-09The date the SEC accepted the filing.
Total Revenue (Q3 2025)$697KIncreased from $51K in Q3 2024, driven by staking rewards.
Net Loss (Q3 2025)$352.8MSignificantly higher than $3.7M loss in Q3 2024, primarily due to derivative and digital asset losses.
Loss on Derivative Liability (9 months ended Sep 30, 2025)$545.7MMajor contributor to the increased net loss.
Unrealized Loss on Digital Assets (9 months ended Sep 30, 2025)$30.5MReflects volatility in SOL holdings.
Total Assets (Sep 30, 2025)$475.9MMassive increase from $3.5M at Dec 31, 2024, largely due to digital asset acquisitions.
Digital Assets (Sep 30, 2025)$350.2MComprises $291.1M unrestricted and $59.1M restricted SOL.
Cash and Cash Equivalents (Sep 30, 2025)$124.1MStrong liquidity position after capital raises.
Net Cash Provided by Financing Activities (9 months ended Sep 30, 2025)$400.7MPrimarily from equity offerings, alleviating going concern doubts.
Class A Common Stock Shares Outstanding (Sep 30, 2025)40,299,228Significantly increased from 4,936 shares at Dec 31, 2024, due to stock issuances.
Basic and Diluted Loss Per Share (Q3 2025)$32.89Reflects the substantial net loss and increased share count.
Central Index Key0001610853Unique identifier for the filer

Related Companies

SOL-USD · HSMT · HMTX · THRN

Frequently Asked Questions

What are the latest SEC filings for Solana Co (HSDT)?

Solana Co has 50 recent SEC filings from May 2024 to Apr 2026, including 34 8-K, 4 10-Q, 3 DEF 14A. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of HSDT filings?

Across 50 filings, the sentiment breakdown is: 1 bullish, 5 bearish, 43 neutral, 1 mixed. The dominant sentiment is neutral.

Where can I find Solana Co SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Solana Co (HSDT) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.

What are the key financial highlights for Solana Co?

Key financial highlights from Solana Co's most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.

What is the investment thesis for HSDT?

The investment thesis for HSDT includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.

Who are the key executives at Solana Co?

Key executives identified across Solana Co's filings include Dr. David L. Smith, Dr. Anya Sharma, Cosmo Jiang, Dane C. Andreeff, Jeffrey S. Mathiesen and 6 others.

What are the main risk factors for Solana Co stock?

Of HSDT's 44 assessed filings, 6 were flagged high-risk, 16 medium-risk, and 22 low-risk.

What are recent predictions and forward guidance from Solana Co?

Forward guidance and predictions for Solana Co are extracted from SEC filings as they are enriched.

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.